Definitive Contract 75A50223C00045
Award Date
9/20/23
Potential Completion Date
3/19/25
Potential Value
$29M
Awardee
Princeton Biomeditech Corp
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Monmouth Junction, South Brunswick Township, NJ 08852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Princeton Biomeditech Corp, doing business as P B M, has been awarded a $1.46 million firm fixed price definitive contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to provide flu testing support for coronavirus. The contract is for the delivery of coronavirus COVID-19 testing services and will be performed in Chamblee, Georgia over a six-month period concluding in September 2020. No subcontractors or set aside designations...
This is a federal contract award from the Department of the Air Force Acquisition COVID-19 Task Force (DAF ACT) to Princeton Biomeditech Corp, doing business as P B M, for $9,885,816.00. The contract supports COVID-19 industrial base expansion efforts, including the development, production, and delivery of coronavirus diagnostics such as rapid, point-of-care tests, multiplex COVID-19 and influenza assays, and test readers. The contract is a definitive, firm-fixed-price contract with a completion...
<p>The U.S. Department of Health and Human Services, through the Office of the Assistant Secretary for Preparedness and Response, has awarded a $4,500,000.00 firm-fixed-price definitive contract to Genabio Diagnostics Inc. for the provision of over-the-counter (OTC) COVID-19 tests. The contract, which is not set aside, has an ultimate completion date of March 19, 2025. This contract award appears to be a standalone acquisition and not part of a larger vehicle.</p>
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $88,704,000 definitive, firm-fixed-price contract to Access Bio, Inc. to provide over-the-counter (OTC) COVID-19 tests from September 2023 through March 2025. Access Bio is a minority-owned, for-profit, Asian-Pacific American-owned manufacturer of medical goods. This award is not associated with any set-aside program. Access Bio has previously received other...
The U.S. Department of Health and Human Services, through the Office of the Assistant Secretary for Preparedness and Response, awarded a $26,510,400 firm-fixed-price definitive contract to Atlantic Trading LLC, a woman-owned small business, for the provision of over-the-counter COVID-19 tests. The contract, which has a period of performance through March 4, 2026, does not have a set-aside designation. Atlantic Trading LLC is a provider of medical supplies and personal protective equipment,...
<p>This is a $31,384,584.00 firm fixed price definitive contract awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Kwell Laboratories LLC, a minority-owned small disadvantaged business, for the delivery of over-the-counter COVID-19 tests. The contract has an ultimate completion date of March 19, 2025. The contract is not set aside and was awarded on September 20, 2023.</p>
This is a $257,060,695.20 firm-fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for the procurement of over-the-counter (OTC) COVID-19 tests. The contract has a completion date of March 30, 2023 and does not utilize a set-aside designation. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products,...
This is a $97,492,572.50 definitive, firm-fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) to Quidel Corp, a manufacturer of medical diagnostics and supplies, for the procurement of over-the-counter (OTC) COVID-19 tests. The contract has an ultimate completion date of April 7, 2028 and does not use a set-aside designation. Quidel Corp, which is based in San Diego, California,...
<p>The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR) awarded a $10.5M definitive contract to Orasure Technologies Inc., doing business as Orasure, to procure over-the-counter (OTC) COVID-19 tests. Orasure will provide the OTC COVID-19 tests from its location in Fountain Hill, Pennsylvania, under a firm fixed price contract running from December 12, 2022 through February 15, 2023.</p>
This is a $49,536,000.00 firm fixed price definitive contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Maxim Biomedical, Inc., a small disadvantaged, woman-owned, Asian-Pacific American-owned business located in Rockville, Maryland. The contract is for the delivery of over-the-counter (OTC) COVID-19 tests with a period of performance through March 19, 2025. Maxim Biomedical has previously received other...